Ratings by H.C. Wainwright (Douglas Tsao)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/3/2024 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2024 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/15/2024 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/9/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/17/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Buy (N/A) |
38.02 (39.85) |
4.81% | Details | |
| 12/21/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2023 | Cerevel Therapeutics | CERE | Downgrade | Neutral (Buy) |
36.93 (41.97) |
13.65% | Details | |
| 12/1/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Outlook Therapeutics Incs. | OTLK | Upgrade | Buy (Neutral) |
0.34 (8.27) |
2332.35% | Details | |
| 10/24/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2023 | Outlook Therapeutics Incs. | OTLK | Downgrade | Neutral (Buy) |
0.27 (8.27) |
2962.96% | Details | |
| 8/18/2023 | AEON Biopharma, Inc | AEON | New Coverage | Buy (N/A) |
4.34 (4.79) |
10.37% | Details | |
| 8/14/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2023 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Minerva Neurosciences | NERV | Maintain | Neutral (N/A) |
|
Details | ||
| 7/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2023 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
39.17 (28.02) |
-28.47% | Details | |
| 5/24/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2023 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | scPharmaceuticals | SCPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Minerva Neurosciences | NERV | Downgrade | Neutral (Buy) |
3.26 (2.50) |
-23.31% | Details | |
| 11/9/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Horizon Therapeutics | HZNP | New Coverage | Neutral (N/A) |
62.32 (116.30) |
86.62% | Details | |
| 10/18/2022 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | argenx SE | ARGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/19/2022 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
44.76 (48.45) |
8.24% | Details | |
| 6/7/2022 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2022 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Neutral (Buy) |
140.00 (39.85) |
-71.54% | Details | |
| 3/4/2022 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2021 | Osmotica | OSMT | New Coverage | Buy (N/A) |
1.06 (1.11) |
4.72% | Details | |
| 12/16/2021 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
18.10 (49.25) |
172.1% | Details | |
| 12/16/2021 | Cerevel Therapeutics | CERE | New Coverage | Buy (N/A) |
30.44 (41.97) |
37.88% | Details | |
| 11/9/2021 | Radius Health | RDUS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/18/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2021 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2021 | Rezolute | RZLT | New Coverage | Buy (N/A) |
6.45 (3.00) |
-53.49% | Details | |
| 5/10/2021 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | argenx SE | ARGX | Upgrade | Buy (Neutral) |
263.70 (375.90) |
42.55% | Details | |
| 5/6/2021 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2021 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2021 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2021 | GW Pharma | GWPH | Downgrade | Buy (Buy) |
211.37 (218.96) |
3.59% | Details | |
| 12/18/2020 | Dare Bioscience | DARE | New Coverage | Buy (N/A) |
1.13 (0.30) |
-73.45% | Details | |
| 12/15/2020 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
121.22 (218.96) |
80.63% | Details | |
| 11/6/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2020 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
11.28 (13.62) |
20.74% | Details | |
| 10/2/2020 | AMAG Pharmaceuticals | AMAG | Downgrade | Neutral (Buy) |
13.65 (13.75) |
0.73% | Details | |
| 8/27/2020 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2020 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2020 | Momenta Pharmaceuticals | MNTA | Downgrade | Neutral (Buy) |
52.15 (52.48) |
0.63% | Details | |
| 8/12/2020 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Immunovant | IMVT | New Coverage | Buy (N/A) |
23.32 (29.26) |
25.47% | Details | |
| 7/29/2020 | argenx SE | ARGX | New Coverage | Neutral (N/A) |
253.23 (375.90) |
48.44% | Details | |
| 7/1/2020 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Chiasma | CHMA | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Minerva Neurosciences | NERV | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2020 | Outlook Therapeutics Incs. | OTLK | Maintain | Buy (Buy) |
|
Details | ||
| 5/18/2020 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | scPharmaceuticals | SCPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Revance Therapeutic | RVNC | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Evolus | EOLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Theravance Biopharma | TBPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2020 | Dermira | DERM | Downgrade | Neutral (Buy) |
18.83 (3.47) |
-81.57% | Details | |
| 10/30/2019 | AMAG Pharmaceuticals | AMAG | Maintain | Buy (Buy) |
|
Details | ||
| 10/30/2019 | Sage Therapeutics | SAGE | New Coverage | Neutral (N/A) |
140.16 (12.95) |
-90.76% | Details | |
| 10/30/2019 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
134.06 (218.96) |
63.33% | Details | |
| 10/15/2019 | scPharmaceuticals | SCPH | New Coverage | Buy (N/A) |
5.90 (4.75) |
-19.49% | Details | |
| 9/25/2019 | Momenta Pharmaceuticals | MNTA | New Coverage | Buy (N/A) |
13.10 (52.48) |
300.61% | Details | |
| 9/4/2019 | Trevena | TRVN | Maintain | Buy (Buy) |
|
Details | ||
| 7/18/2019 | Outlook Therapeutics Incs. | OTLK | New Coverage | Buy (N/A) |
2.02 (8.27) |
309.41% | Details | |
| 7/8/2019 | Protagonist Therapeutics | PTGX | New Coverage | Buy (N/A) |
12.50 (27.14) |
117.12% | Details | |
| 5/31/2019 | Trevena | TRVN | New Coverage | Buy (N/A) |
1.19 (0.38) |
-68.07% | Details | |
| 3/27/2019 | Dermira | DERM | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2019 | Radius Health | RDUS | New Coverage | Neutral (N/A) |
19.60 (17.97) |
-8.32% | Details | |
| 2/14/2019 | Crinetics | CRNX | New Coverage | Buy (N/A) |
24.86 (44.23) |
77.92% | Details | |
| 2/14/2019 | Revance Therapeutic | RVNC | New Coverage | Buy (N/A) |
17.86 (3.77) |
-78.89% | Details | |
| 2/14/2019 | Evolus | EOLS | New Coverage | Buy (N/A) |
26.56 (11.90) |
-55.2% | Details | |
| 2/14/2019 | Chiasma | CHMA | New Coverage | Buy (N/A) |
3.53 (3.79) |
7.37% | Details |
